![A. Keith Willard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
A. Keith Willard
Keine laufenden Positionen mehr
Profil
A.
Keith Willard served as Chairman & CEO at Zeneca, Inc. from 1999 to 1999.
He was President & Director at ICI Canada, Inc. from 1993 to 1999.
He also served as an Independent Director at Inhibitex LLC from 2011 to 2012.
Willard received his undergraduate degree from McGill University and another undergraduate degree from Concordia University.
Ehemalige bekannte Positionen von A. Keith Willard
Unternehmen | Position | Ende |
---|---|---|
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Direktor/Vorstandsmitglied | 13.02.2012 |
ICI Canada, Inc. | Präsident | 01.10.1999 |
Zeneca, Inc. | Vorsitzender | 01.01.1999 |
Ausbildung von A. Keith Willard
Concordia University | Undergraduate Degree |
McGill University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
ICI Canada, Inc. | |
Zeneca, Inc. |